Background
==========

The heart is an extremely important dynamic organ. The development of the heart is complex and involves many signaling pathways and transcription factors \[[@b1-medscimonit-25-2756]--[@b3-medscimonit-25-2756]\]. Many factors, such as environment factors, maternal factors, special medicine taken during pregnancy, genetic variations and so on \[[@b4-medscimonit-25-2756]--[@b9-medscimonit-25-2756]\], may disturb these regulated factors and lead to an aberrant structure and function of the heart, potentially resulting in congenital heart disease (CHD). CHD includes atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus, tetralogy of Fallot and so on. Among them, ASD is one of the most common subtypes of CHD \[[@b10-medscimonit-25-2756]\].

Human *NKX2-5*, murine *Nkx2-5*, and*Drosophila tinman* all belong to the NK homeobox gene family, which includes a conserved homeodomain \[[@b11-medscimonit-25-2756]\] and plays a crucial role in the development of the heart, regulating the proliferation, differentiation, and electrophysiological properties of cardiac cells. In mice, *Nkx2-5* is expressed in progenitor cells of the heart in the first heart field (FHF), second heart field (SHF), and pharyngeal endoderm \[[@b12-medscimonit-25-2756],[@b13-medscimonit-25-2756]\], and it is necessary and sufficient for the development of the SHF \[[@b13-medscimonit-25-2756]\] and a determinate of differentiation into the myocardial lineage \[[@b12-medscimonit-25-2756]\]. In the SHF of mice, *NKx2-5* regulates the proliferation of heart progenitors and the morphology of the outflow tract \[[@b14-medscimonit-25-2756]\]. In zebrafish, *Nkx* genes regulate electrophysiological patterning \[[@b15-medscimonit-25-2756]\]. Mutations in murine*NKx2-5* result in embryonic death and an abnormal structure and function of heart, including contraction defects, valvular dysmorphogenesis, atrial septal defect, ventricular noncompaction cardiomyopathy, and arrhythmias \[[@b16-medscimonit-25-2756]--[@b22-medscimonit-25-2756]\].

The aforementioned results demonstrate that *NKx2-5* is a core regulatory transcription factor in cardiogenesis, and that disruption of*NKx2-5* results in an abnormal structure and function of heart. However, the pathogenic mechanism of *NKX2-5* in Chinese patients with sporadic atrial septal defect is unclear. To investigate the genetic variation of *NKX2-5* in Chinese patients with sporadic atrial septal defect, we performed sequence analysis on full length *NKX2-5.*

Material and Methods
====================

Study participants
------------------

For this study, 439 patients with sporadic atrial septal defect (157 males and 282 females) and 567 healthy unrelated individuals (274 males and 293 females) were recruited. Patients were recruited from the Department of Cardiovascular Surgery at Yan'an Affiliated Hospital of Kunming Medical University. Healthy unrelated individuals, confirmed by a medical examination and cardiac color Doppler ultrasound, were recruited from our previous epidemiological investigation. The ethnic groups of the participants included Han, Bai, Yi, Dai, and so on. There was no obvious ethnic group difference between the patients and the healthy controls. Diagnosis of ASD was confirmed by cardiac color Doppler ultrasound and findings during cardiac surgery, and other CHDs, such as ventricular septal defect, tetralogy of Fallot, Ebstein anomaly, patent ductus arteriosus, endocardial cushion defect, and Holt-Oram syndromes, were exclusion criteria for this study. This study was approved by the institutional research ethics committee of Yan'an Affiliated Hospital of Kunming Medical University. All participants or their parents provided informed consent. Genomic DNA was extracted from the peripheral blood leukocytes of the participants.

Primers
-------

Primers ([Table 1](#t1-medscimonit-25-2756){ref-type="table"}) were designed to amplify full-length *NKX2-5*. The specificity and efficiency of the primers was validated by polymerase chain reaction (PCR). The amplification system and experimental procedure of PCR are described in the supplementary data ([Supplementary Tables 1](#s1-medscimonit-25-2756){ref-type="supplementary-material"}, [2](#s2-medscimonit-25-2756){ref-type="supplementary-material"}).

Multiplex PCR and qPCR
----------------------

Multiplex PCR was performed twice to amplify full-length *NKX2-5*. The amplification system and experimental procedure of multiplex PCR are described in the supplementary data ([Supplementary Tables 3](#s3-medscimonit-25-2756){ref-type="supplementary-material"}--[6](#s6-medscimonit-25-2756){ref-type="supplementary-material"}). The accuracy and efficiency of the multiplex PCR were validated by quantitative polymerase chain reaction (qPCR). The amplification system and experimental procedure of qPCR are described in the supplementary data ([Supplementary Tables 7](#s7-medscimonit-25-2756){ref-type="supplementary-material"}, [8](#s8-medscimonit-25-2756){ref-type="supplementary-material"}).

Variation detection and statistical analysis
--------------------------------------------

The products of multiplex PCR were mixed to form the sequencing library. An Illumina HiSeq platform was used to sequence the library. Human reference genome sequences (Edition: GRCh38.p7) and Burrows-Wheeler Alignment (BWA) (Edition: 0.1.22) were used to compare the sequences of the samples with the standard reference genome sequences. Detection of variation was processed by a genome analysis toolkit (GATK, Edition: v3.1). An online software variant effect predictor was used to annotate the variation. A square test was used to compare the 2 samples. SPSS 22.0 (IBM, USA) was used to analyze the data. A *P*-value \<0.05 was used to indicate a statistically significant difference.

Results
=======

Collation and statistics of raw data
------------------------------------

The Q30 for all of the samples was greater than 90%. The total reads of *NKX2-5* were 147 014 508 bp. After filtering, the reads of *NKX2-5* were 145502856 bp. The total reads of *NKX2-5* matched to the reference sequence were 79 266 998 bp. After filtering, the corrected reads were 66 473 696 bp. The average depth of the sequencing of each amplicon was approximately 5800-fold.

Thirty variations detected in 439 patients
------------------------------------------

Through comparison with the standard reference genome sequences, 30 variations ([Supplementary Table 9](#s9-medscimonit-25-2756){ref-type="supplementary-material"}) were detected in patients. The 30 variations included 18 single nucleotide polymorphisms (SNPs) and 12 novel variations (without rs number). The 18 SNPs were rs2277923, rs703752, rs3131915, rs3729753, rs376790353, rs549757001, rs562842387, rs531139209, rs892817393, rs1004442524, rs540202205, rs375010127, rs202071628, rs553775519, rs759221178, rs767243751, rs72554029, and rs551687864. The 12 novel variations, described as chromosomal locations, are 173233943, 173234153, 173233940, 173233733, 173232329, 173233307, 173234249, 173235293, 173234696, 173234963, 173235001, and 173233307. Six SNPs of the 30 variations had a high frequency greater than 1%. The 6 high-frequency SNPs in the 439 patients are listed in [Table 2](#t2-medscimonit-25-2756){ref-type="table"}.

Two SNPs detected in 567 healthy controls
-----------------------------------------

Two SNPs ([Table 3](#t3-medscimonit-25-2756){ref-type="table"}) were detected in healthy controls. These SNPs were rs703752 and rs2277923 and had frequencies of 68.78% and 15.17%, respectively.

rs2277923 and rs3729753 are prominent SNVs with a high frequency and odds ratio in patients
-------------------------------------------------------------------------------------------

Among the 30 variations, rs2277923 and rs3729753 were prominent with a high frequency and odds ratio ([Table 4](#t4-medscimonit-25-2756){ref-type="table"}) in patients.

Discussion
==========

In this study, we sequenced full-length *NKX2-5* and detected 30 variations of *NKX2-5* in Chinese patients with sporadic atrial septal defect. Six of the 30 variations had a frequency greater than 1%. The SNPs rs2277923 and rs3729753 were prominent SNVs with a high frequency and odds ratio in Chinese patients with sporadic atrial septal defect.

Human *NKX2-5* consisted of 3218 bp located at 5q35.1 and encoded 3 isoforms through pre-RNA splicing. The 3 isoforms were isoform 1, isoform 2, and isoform 3. Isoform 1 has the homeodomain, which is strictly expressed in the heart, and is the most abundant isoform in heart tissue. Isoform 2 and isoform 3 lack the homeodomain and have a low abundance in heart tissue \[[@b23-medscimonit-25-2756]\]. Isoform 1 consists of 324 amino acids, which contain an evolutionarily conserved homeodomain-containing domain (HD, amino acids 138--197) in the middle, a tinman domain (TN, amino acids 10--21) at the N-terminus, a nuclear localization signal (NLS) near the N-terminus of the homeodomain, a NK2-specific domain (NK2, amino acids 212--234) at the C-terminus \[[@b11-medscimonit-25-2756],[@b24-medscimonit-25-2756]--[@b26-medscimonit-25-2756]\], and a tyrosine-rich homophilic interaction domain (YRD) near the NK2 domain \[[@b27-medscimonit-25-2756],[@b28-medscimonit-25-2756]\]. The HD domain is involved in DNA binding activity and transcriptional activation \[[@b29-medscimonit-25-2756]\]. The NLS domain could influence the location of NKX2-5 by phosphorylation and dephosphorylation \[[@b30-medscimonit-25-2756]\]. The NK2 domain functions as a regulator of transcriptional activation \[[@b31-medscimonit-25-2756]\]. The YRD domain is essential for the function of NKX2-5 in cardiogenesis and embryonic development \[[@b27-medscimonit-25-2756]\]. The function of the TN domain is still unclear. As a crucial transcriptional factor, NKX2-5 is a regulator of the development of the heart \[[@b1-medscimonit-25-2756]--[@b3-medscimonit-25-2756],[@b32-medscimonit-25-2756],[@b33-medscimonit-25-2756]\] that functions by binding its downstream targets through its functional domain, such as the HD domain, TN domain, NK domain, and YRD domain \[[@b28-medscimonit-25-2756],[@b31-medscimonit-25-2756],[@b34-medscimonit-25-2756],[@b35-medscimonit-25-2756]\].

In this study, we detected 30 genetic variations of *NKX2-5* in patients with sporadic atrial septal defect, and no frameshift mutations or insertion/deletion mutations were detected. These results demonstrate that single nucleotide variations (SNVs) are the prominent genetic variations of *NKX2-5* in Chinese patients with sporadic atrial septal defect. Among them, 6 SNPs had a high frequency greater than 1%. These SNPs were distributed in the exons, introns, and 3′UTR of *NKX2-5*. Although these SNPs did not change the amino acid sequence and structure of the domains of NKX2-5, we still considered these variations, especially the SNPs rs2277923 and rs3729753, to have the potential and ability to cause sporadic atrial septal defect for the following reasons. First, compared with healthy people, patients with sporadic atrial septal defect had a high frequency of and odds ratio for rs2277923 and rs3729753. Second, although synonymous SNVs did not change the structure of the protein, a synonymous SNV can influence the structure of the pre-RNA and the binding to RNA binding protein \[[@b36-medscimonit-25-2756],[@b37-medscimonit-25-2756]\]. Pre-RNA of *NKX2-5* was spliced through an alternative splicing mechanism to generate 3 isoforms. The presence of an SNV may influence the recognition and binding of the RNA binding protein and spliceosomes. The presence of an SNV may also influence the stability and degradation of RNA in the cytoplasm \[[@b36-medscimonit-25-2756],[@b37-medscimonit-25-2756]\]. Third, as a crucial transcription factor, the regulatory functions of NKX2-5 depended on its quality and abundance. SNV might influence the RNA level, resulting in changes in the abundance and distribution of the transcript of*NKX2-5*, which then disturbs the downstream targets of NKX2-5.

Conclusions
===========

Single nucleotide variations are the prominent genetic variations of *NKX2-5* in Chinese patients with sporadic atrial septal defect. The SNPs rs2277923 and rs3729753 are prominent SNVs in Chinese patients with sporadic atrial septal defect. A pathogenic mechanism of rs2277923 and rs3729753 may exist at the RNA level. Further studies are needed to validate this possibility.

Supplementary Tables
====================

###### 

Amplification system of PCR.

  Reagent component         Volume   Concentration
  ------------------------- -------- ---------------
  Buffer (10×)              1 uL     
  Primer (1 uM)             2 uL     
  dNTP (2.5 mM)             0.8 uL   
  DNA polymerase (5 U/uL)   0.1 uL   1×
  Template DNA              2 uL     
  Mg~2~+ (100 mM)           1 uL     
  ddH~2~O                   3.2 uL   
  Paraffin oil              10 uL    

###### 

Experimental procedure of PCR.

  Step   Temperature   Time     Cycle
  ------ ------------- -------- -----------
  1      95°C          15 min   1 cycle
  2      94°C          30 s     
  3      60°C          90 s     35 cycles
  4      72°C          30 s     
  5      72°C          10 min   1 cycle

###### 

Amplification system of the first turn multiplex PCR.

  Reagent component         Volume   Concentration
  ------------------------- -------- ---------------
  Buffer (10×)              1 uL     
  Primer (50 nM)            2 uL     
  dNTP (2.5 mM)             0.8 uL   
  DNA polymerase (5 U/uL)   0.1 uL   1×
  Template DNA              2 uL     
  Mg~2~+ (100 mM)           1 uL     
  ddH~2~O                   3.2 uL   
  Paraffin oil              10 uL    

###### 

Experimental procedure of the first turn multiplex PCR.

  Step   Temperature   Time     Cycle
  ------ ------------- -------- ----------
  1      95°C          15 min   1 cycle
  2      94°C          30 s     
  3      60°C          10 min   4 cycles
  4      72°C          30 s     
  5      94°C          30 s     
  6      60°C          1 min    20 cycle
  7      72°C          30 s     

###### 

Amplification system of the second turn multiplex PCR.

  Reagent component         Volume   Concentration
  ------------------------- -------- ---------------
  Buffer (10×)              2 uL     
  Barcode (2 uM)            3.6 uL   
  dNTP (2.5 mM)             0.8 uL   
  DNA polymerase (5 U/uL)   0.1 uL   1×
  Template DNA              10 uL    
  Mg~2~+ (100 mM)           1 uL     
  ddH~2~O                   3.6 uL   
  Paraffin oil              20 uL    

###### 

Experimental procedure of the second turn multiplex PCR.

  Step   Temperature   Time     Cycle
  ------ ------------- -------- ----------
  1      95°C          15 min   1 cycle
  2      94°C          30 s     
  3      60°C          4 min    5 cycles
  4      72°C          30 s     
  5      94°C          30 s     
  6      65°C          1 min    10 cycle
  7      72°C          30 s     

###### 

Amplification system of qPCR.

  Reagent component   Volume    Concentration
  ------------------- --------- ---------------
  Mix                 6 uL      
  Primer (1 uM)       2 uL      
  Template DNA        1.8 uL    1×
  ROX                 0.24 uL   
  ddH~2~O             2 uL      

###### 

Experimental procedure of qPCR.

  Step   Temperature   Time    Cycle
  ------ ------------- ------- -----------
  1      95°C          2 min   1 cycle
  2      94°C          30 s    
  3      60°C          30 s    35 cycles
  4      72°C          30 s    

###### 

30 variations detected in 439 patients.

  LOC         rs number      REF   ALT   SNP (n=439)   Frequency (%)
  ----------- -------------- ----- ----- ------------- ---------------
  173235021   rs2277923      T     C     352           80.18
  173232508   rs703752       C     A     73            16.63
  173233891   rs3131915      C     G     68            15.49
  173232938   rs3729753      C     G     21            4.78
  173233982   rs376790353    C     A     9             2.05
  173233290   rs549757001    G     A     8             1.82
  173233943   None           C     A     4             0.91
  173232370   rs562842387    C     T     3             0.68
  173234153   None           A     G     2             0.46
  173234425   rs531139209    C     G     2             0.46
  173233698   rs892817393    A     G     2             0.46
  173233940   None           G     T     2             0.46
  173234640   rs1004442524   C     T     2             0.46
  173232273   rs540202205    C     G     2             0.46
  173233733   None           G     A     1             0.23
  173232340   rs375010127    T     C     1             0.23
  173232839   rs202071628    C     G     1             0.23
  173232329   None           G     T     1             0.23
  173232316   rs553775519    G     T     1             0.23
  173233307   None           A     T     1             0.23
  173234249   None           C     T     1             0.23
  173235293   None           G     C     1             0.23
  173234696   None           T     C     1             0.23
  173234775   rs759221178    G     A     1             0.23
  173234784   rs767243751    G     T     1             0.23
  173234847   rs72554029     C     G     1             0.23
  173234963   None           G     A     1             0.23
  173235001   None           G     A     1             0.23
  173233307   None           A     T     1             0.23
  173233409   rs551687864    G     A     1             0.23

LOC -- position in the chromosome; REF -- reference genomic locus information; ALT -- locus variation information in the sample.

**Source of support:** This work was supported by grants from National Natural Science Foundation of China (No. 81560060, 31160230, 81760059), Project of "YUN LING Scholar" and Yunnan/Kunming Key Laboratory of Cardiovascular Surgery

###### 

Primers for multiplex PCR.

  ID of amplicons   Primer sequence              
  ----------------- ---------------------------- ---------------------------
  Primer1.1-F       TTCCAGCAAGGGTTAGGTTTT        GCACCCACCCGTATTTATGTTT
  Primer1.2-F       ACACGTGCGGGGTCAACG           GAGAGTCCATGGGCACCCC
  Primer1.3-F       CCCTGGCTCGCGGAATG            TGCGGAGACCTAGGAACTTTT
  Primer1.4-F       CAGGATCACTCATTGCACGC         CCGAGCCTGGTAGGGAAGG
  Primer1.5-F       CATGTTGGGAGCCCCTTCTC         CTGCCGCCGCCAACAA
  Primer1.6-F       GGAATCCCGGGGCTCTG            GCCTGCCTACGGCGTGG
  Primer1.7-F       CGCGCCGCCGTAACC              GCAGGACCAGACTCTGGAGC
  Primer1.8-F       CACTGGCACCGCGATCC            TCGCAGGCGCAGGTCTAT
  Primer1.9-F       CGTGGACGTGAGTTTCAGCAC        GCGCTGCAGAAGGCGG
  Primer1.10-F      GTCCGCCTCTGTCTTCTCCA         TGTCGGTGGCTCCCAGTG
  Primer1.11-F      GTAAGAGCGGCTTGACCTACG        CGTCTGTCTCCCTCACCAGG
  Primer1.12-F      TAGAAAGTCAGGCTGGCTCAA        TCTGTTCATTTAACTTCTCAAACCA
  Primer1.13-F      AAACCAGGTGATGCTCTGGG         CCCGCAGCTTCTTGGACAC
  Primer1.14-F      CAAAATTAAGGAATCAAGAAACAGAA   TTTGTTGAGGAGCAGAGGCC
  Primer1.15-F      GGCTTCCTCGAATTGGTAGC         CCCCGCTGCAGAAAGGG
  Primer1.16-F      TTCGCCCAGCGCTTCG             GGGCGGAGAGGTTCCCTC
  Primer1.17-F      CACTCATCTCGTCCACTCCCTT       GGGTTTCTGGTGCCTTTCTT
  Primer1.18-F      GGTCCGCAGTATCCCATTTTAA       TCTCCTTTGGATTTACGAATCTTT
  Primer1.19-F      GATTGTACGCAAAAGCTGTCTG       GGCCTAACAAAGCCCCGG
  Primer1.20-F      GATTTCTCAACTTCCTACCAGACC     GAGACACGCGCCCTTGG
  Primer1.21-F      TCTGAACCTCCGATTGGACG         CCAGCCAAGGACCCTAGAGC
  Primer1.22-F      GACCCAGGAGGGGAGAAGG          TCAAGCCAGAGGCCTACGCT
  Primer1.23-F      GAAAGGCAGACGCACACTTG         TCAAAGACATCCTAAACCTGGAA
  Primer1.24-F      GCCAGGGTCGCCTCCA             GCGGCACCATGCAGGG
  Primer1.25-F      GGCAGCGCCAGTCTCACA           GGCCCCTGGCCCAATG
  Primer1.26-F      AGCAGGTAGCGCTGAGCACA         CCTTCCAAATGCGTCGTGG

###### 

Six high-frequency SNPs detected in 439 patients.

  LOC1        rs number     REF   ALT   AAC          LOC2     SNP (n=439)   Frequency (%)
  ----------- ------------- ----- ----- ------------ -------- ------------- ---------------
  173235021   rs2277923     T     C     Glu \> Glu   Extron   352           80.18
  173232508   rs703752      C     A     None         3/UTR    73            16.63
  173233891   rs3131915     C     G     None         Intron   68            15.49
  173232938   rs3729753     C     G     Leu \> Leu   Extron   21            4.78
  173233982   rs376790353   C     A     None         Intron   9             2.05
  173233290   rs549757001   G     A     None         Intron   8             1.82

LOC1 -- position in the chromosome; REF -- reference genomic locus information; ALT -- locus variation information in the sample; AAC -- amino acid change; LOC2 -- position in the *NKX2-5*; SNPs -- single nucleotide polymorphisms.

###### 

Two SNPs detected in healthy controls.

  LOC1        rs number   REF   ALT   AAC        LOC2     SNP (n=567)   Frequency (%)
  ----------- ----------- ----- ----- ---------- -------- ------------- ---------------
  173232508   rs703752    C     A     none       3/UTR    390           68.78
  173235021   rs2277923   G     A     Glu\>Glu   Extron   86            15.17

LOC1 -- position in the chromosome; REF -- reference genomic locus information; ALT -- locus variation information in the sample; AAC -- amino acid change; LOC2 -- position in the *NKX2-5*; SNPs -- single nucleotide polymorphisms.

###### 

χ^2^, *P*-value and OR of SNPs in ASD versus control.

  SNP           ASD (n=439)   Control (n=567)   χ^2^, *P*-value         OR, 95%CI
  ------------- ------------- ----------------- ----------------------- -------------------------
  rs2277923     352           86                χ^2^=425.45, P\<0.001   5.286 (4.328--6.458)
  rs3729753     21            0                 χ^2^=27.70, P\<0.001    27.123 (3.663--200.858)
  rs703752      73            390               χ^2^=270.92, P\<0.001   0.242 (0.195--0.300)
  rs202071628   1             0                 χ^2^=1.293, P=0.256     0.998 (0.993--1.002)

OR -- odds ratio; ASD -- atrial septal defect; SNP -- single nucleotide polymorphisms.
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